France Real Time PCR qPCR Market

ID: MRFR/HC/43655-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
France Real-Time PCR qPCR Market Research Report: Size, Share, Trend Analysis By Product (Reagents Consumables, Instruments, Software Services), By Applications (Clinical, Research, Forensics) and By End Users (Hospitals Centers, Research Laboratories Academic Institutes, Pharmaceutical Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

France Real Time PCR qPCR Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)4.99%
2024 Market Size$ 293.4 Million
2025 Market Size$ 308.04 Million
2035 Market Size$ 501 Million

Key Players

Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Abbott Laboratories
Agilent Technologies
Opportunities
  • Rising Healthcare Expenditure
  • Expansion of Biotechnology Sector
  • Rising Awareness of Personalized Medicine
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Food, Beverages & Nutrition, BY Product (USD Million)
      1. 4.1.1 Reagents & Consumables
      2. 4.1.2 Instruments
      3. 4.1.3 Software & Services
    2. 4.2 Food, Beverages & Nutrition, BY Application (USD Million)
      1. 4.2.1 Clinical
      2. 4.2.2 Research
      3. 4.2.3 Forensics
    3. 4.3 Food, Beverages & Nutrition, BY End-user (USD Million)
      1. 4.3.1 Hospitals & Diagnostic Centers
      2. 4.3.2 Research Laboratories & Academic Institutes
      3. 4.3.3 Pharmaceutical & Biotechnology Companies
      4. 4.3.4 Clinical Research Organizations
      5. 4.3.5 Forensic Laboratories
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Thermo Fisher Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bio-Rad Laboratories (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Roche Diagnostics (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Qiagen (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Abbott Laboratories (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Agilent Technologies (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 PerkinElmer (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Merck KGaA (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 FRANCE MARKET ANALYSIS BY PRODUCT
    3. 6.3 FRANCE MARKET ANALYSIS BY APPLICATION
    4. 6.4 FRANCE MARKET ANALYSIS BY END-USER
    5. 6.5 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
    8. 6.8 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    10. 6.10 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
    11. 6.11 FOOD, BEVERAGES & NUTRITION, BY PRODUCT, 2024 (% SHARE)
    12. 6.12 FOOD, BEVERAGES & NUTRITION, BY PRODUCT, 2024 TO 2035 (USD Million)
    13. 6.13 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 (% SHARE)
    16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END-USER, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

France Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Product (USD Million, 2025-2035)

  • Reagents & Consumables
  • Instruments
  • Software & Services

Food, Beverages & Nutrition By Application (USD Million, 2025-2035)

  • Clinical
  • Research
  • Forensics

Food, Beverages & Nutrition By End-user (USD Million, 2025-2035)

  • Hospitals & Diagnostic Centers
  • Research Laboratories & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Clinical Research Organizations
  • Forensic Laboratories